Abivax SA American Depositary Shares
Stock Chart, Company Information, and Scan Results
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Abivax SA American Depositary Shares Company Information, Fundamentals, and Technical Indicators
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Abivax SA American Depositary Shares In Our Stock Scanner
As of Oct 13, 2025Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.